National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting, 9587 [2011-3765]

Download as PDF Federal Register / Vol. 76, No. 34 / Friday, February 18, 2011 / Notices Time: 9 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call.) Contact Person: David M. Armstrong, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center/ Room 6138/MSC 9608, 6001 Executive Boulevard, Bethesda, MD 20892–9608. 301– 443–3534. armstrda@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: February 11, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. This notice is being published less than 15 days prior to the meeting due to timing limitations imposed by the review funding cycle. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group; Neurological Sciences and Disorders A. Date: March 2, 2011. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Argonaut Hotel, 495 Jefferson Street, San Francisco, CA 94109. Contact Person: Richard D Crosland, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529. 301–496–9223. croslanr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: February 11, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–3774 Filed 2–17–11; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2011–3770 Filed 2–17–11; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings WReier-Aviles on DSKGBLS3C1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group; Neurological Sciences and Disorders B. Date: February 24, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sir Francis Drake Hotel, 450 Powell Street at Sutter, San Francisco, CA 94102. Contact Person: Ernest W Lyons, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529. 301– 496–4056. Lyonse1@mail.nih.gov. VerDate Mar<15>2010 13:57 Feb 17, 2011 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on March 11, 2011, from 8:30 a.m. to 3:45 p.m. at the Bethesda Marriott Suites, 6711 Democracy Blvd., Bethesda, MD 20817. The meeting will be open to the public from 8:30 a.m. until 2 p.m.; the DMICC will meet in closed session from 2:10 p.m. until 3:45 p.m. Attendance is limited to space available. Non-Federal individuals planning to attend the meeting should notify the Contact Person listed on this notice at least 2 days prior to the meeting. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed below at least 10 days in advance of the meeting. The DMICC facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for PO 00000 Frm 00054 Fmt 4703 Sfmt 9990 9587 members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The March 11, 2011, DMICC meeting will discuss ‘‘Diabetes: A1c/Questions/ Diagnosis.’’ Any member of the public interested in presenting oral comments to the Committee should notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present oral comments and presentations will be limited to a maximum of five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, oral comments will be allowed on a first come, first serve basis. A registration link and information about the DMICC meeting will be available on the DMICC Web site: https://www.diabetescommittee.gov. Members of the public who would like to receive e-mail notification about future DMICC meetings could register on a listserv available on the same Web site. For further information concerning this meeting contact Dr. Sanford Garfield, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Room 654, MSC 5460, Bethesda, MD 20892–5460, Telephone: 301–594–8803 FAX: 301–402–6271, E-mail: dmicc@mail.nih.gov. Dated: February 14, 2011. Sanford Garfield, Executive Secretary, DMICC, Division of Diabetes, Endocrinology and Metabolic Diseases, NIDDK, National Institutes of Health. [FR Doc. 2011–3765 Filed 2–17–11; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\18FEN1.SGM 18FEN1

Agencies

[Federal Register Volume 76, Number 34 (Friday, February 18, 2011)]
[Notices]
[Page 9587]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3765]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases 
Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting

    The Diabetes Mellitus Interagency Coordinating Committee (DMICC) 
will hold a meeting on March 11, 2011, from 8:30 a.m. to 3:45 p.m. at 
the Bethesda Marriott Suites, 6711 Democracy Blvd., Bethesda, MD 20817. 
The meeting will be open to the public from 8:30 a.m. until 2 p.m.; the 
DMICC will meet in closed session from 2:10 p.m. until 3:45 p.m. 
Attendance is limited to space available. Non-Federal individuals 
planning to attend the meeting should notify the Contact Person listed 
on this notice at least 2 days prior to the meeting. Individuals who 
plan to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should inform the 
Contact Person listed below at least 10 days in advance of the meeting.
    The DMICC facilitates cooperation, communication, and collaboration 
on diabetes among government entities. DMICC meetings, held several 
times a year, provide an opportunity for members to learn about and 
discuss current and future diabetes programs in DMICC member 
organizations and to identify opportunities for collaboration. The 
March 11, 2011, DMICC meeting will discuss ``Diabetes: A1c/Questions/
Diagnosis.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the Contact Person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present oral 
comments and presentations will be limited to a maximum of five 
minutes. Both printed and electronic copies are requested for the 
record. In addition, any interested person may file written comments 
with the Committee by forwarding their statement to the Contact Person 
listed on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person. Because of time constraints for 
the meeting, oral comments will be allowed on a first come, first serve 
basis.
    A registration link and information about the DMICC meeting will be 
available on the DMICC Web site:  https://www.diabetescommittee.gov. 
Members of the public who would like to receive e-mail notification 
about future DMICC meetings could register on a listserv available on 
the same Web site.
    For further information concerning this meeting contact Dr. Sanford 
Garfield, Executive Secretary of the Diabetes Mellitus Interagency 
Coordinating Committee, National Institute of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Boulevard, Room 654, MSC 5460, 
Bethesda, MD 20892-5460, Telephone: 301-594-8803 FAX: 301-402-6271, E-
mail: dmicc@mail.nih.gov.

    Dated: February 14, 2011.
Sanford Garfield,
Executive Secretary, DMICC, Division of Diabetes, Endocrinology and 
Metabolic Diseases, NIDDK, National Institutes of Health.
[FR Doc. 2011-3765 Filed 2-17-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.